BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2013
View Archived Issues
IRX-4204 shows efficacy in a number of preclinical and early clinical studies
Read More
Axon Neuroscience creates vaccine against modified tau protein
Read More
MHC class I-restricted vaccines prove clinically active against metastatic RCC
Read More
Ottawa Hospital Research Institute receives grant to investigate childhood brain cancer
Read More
Researchers present data from the ASCEND-HF trial
Read More
Tho1 protein as a new biomarker of early PSA recurrence in prostate cancer
Read More
The HER3 signaling pathway as a novel therapeutic target in MPNST
Read More
Scientists to develop gold-plated microchip to detect cancer growth
Read More
Promising antioxidant and Abeta properties demonstrated for YK-171
Read More
Prima BioMed earns grant to support development of CVac
Read More
Star Scientific reports preclinical anatabine data in ulcerative colitis
Read More
Cerecor obtains worldwide rights to Merck & Co.'s COMT inhibitors
Read More
DART Therapeutics obtains rights to SARM candidate for DMD
Read More
PARD-3 protein overexpression is associated with poor prognosis in ccRCC
Read More
Ipsen and Inspiration close sale of OBI-1 to Baxter International
Read More
New agents for hepatitis synthesized at Lupin
Read More
Novartis and IRM disclose novel PDGFR inhibitors
Read More
Wockhardt designs new series of antibacterial agents
Read More
Novartis synthesizes new product for COPD
Read More
Affinium Pharmaceuticals reports data from phase IIa trial of AFN-1252
Read More
New protein kinase inhibitors divulged by New Hope R&D Bioscience
Read More
Arbovax completes preclinical study of tetravalent dengue fever vaccine
Read More
Elafin granted second FDA orphan drug designation
Read More
Amorfix continues preclinical development of blood test for ALS
Read More
FDA committee recommends approval of Probuphine
Read More
Enrollment begins in FREEDOM phase III program for once- or twice-yearly diabetes therapy
Read More